Takeda: European Commission Grants Marketing Authorization F

TOKYO (dpa-AFX) - Takeda (TAK) announced the European Commission granted marketing authorization for the company's dengue vaccine QDENGA for the prevention of dengue disease in individuals from

Related Keywords

Tokyo , Japan , , European Union , European Commission , European Medicines Agency , More Such Health News , Takeda , European , Commission , Migrants , Marketing , Authorization , Dengue , Vaccine , Udenga ,